WFH Advocates for Hemophilia Care Access at WHO EMRO Meeting in Cairo
World Federation of Hemophilia / Fédération mondiale de l’hémophilie posted on LinkedIn:
”During the 72nd Session of the WHO Regional Committee for the Eastern Mediterranean in Cairo, Egypt, WFH Regional Manager Rana Saifi delivered a statement advocating for the inclusion of hemophilia and other Bleeding Disorders in the WHO EMRO flagship initiative to expand access to quality medical products in the region.
This aligns with the recent WHO 2025 Essential Medicines List updates, a critical step forward that requires concrete regional and national action to ensure access to lifesaving treatments.
Saifi also voiced WFH’s strong support for a WHA resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Inherited Bleeding Disorders, proposed for discussion at the 158th session of the WHO Executive Board and backed by several Member States including Armenia, Morocco, with support from Egypt, Nepal and Sri Lanka.
Read the full statement here.”
Stay updated with Hemostasis Today.
-
Jul 23, 2026, 10:33Johanna Rodríguez: The Structural Challenge of Next-Gen Anticoagulants
-
Jul 23, 2026, 10:27Logan Hamilton: New Study Identifies the Mutated Antibody Gene Responsible for VITT
-
Jul 23, 2026, 09:05Fonkou Steve: What If We’ve Been Asking the Wrong Question About Plasma Too?
-
Jul 23, 2026, 08:27Registration Is Now Open for ASH 2026
-
Jul 23, 2026, 08:19Sheeza Nawaz: Why Do Patients With Aortic Stenosis Bleed?
-
Jul 23, 2026, 07:59Paschalis Karakasis: Can Left Atrial Appendage Closure Truly Replace Oral Anticoagulation?
-
Jul 23, 2026, 06:53Lakmali Silva: What Makes ISTH More Than a Scientific Meeting?
-
Jul 23, 2026, 05:48Paschalis Evangelidis: Rethinking Pulmonary Embolism Through the Lens of Thromboinflammation
-
Jul 23, 2026, 05:35Neil Morgan: Honoured to Lead the Platelet and Megakaryocyte Theme at ISTH 2026